78 related articles for article (PubMed ID: 25110098)
1. Targeted delivery of cisplatin by сonnexin 43 vector nanogels to the focus of experimental glioma C6.
Nukolova NV; Baklaushev VP; Abakumova TO; Mel'nikov PA; Abakumov MA; Yusubalieva GM; Bychkov DA; Kabanov AV; Chekhonin VP
Bull Exp Biol Med; 2014 Aug; 157(4):524-9. PubMed ID: 25110098
[TBL] [Abstract][Full Text] [Related]
2. Treatment of poorly differentiated glioma using a combination of monoclonal antibodies to extracellular connexin-43 fragment, temozolomide, and radiotherapy.
Yusubalieva GM; Baklaushev VP; Gurina OI; Zorkina YA; Gubskii IL; Kobyakov GL; Golanov AV; Goryainov SA; Gorlachev GE; Konovalov AN; Potapov AA; Chekhonin VP
Bull Exp Biol Med; 2014 Aug; 157(4):510-5. PubMed ID: 25110095
[TBL] [Abstract][Full Text] [Related]
3. Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1.
Baklaushev VP; Nukolova NN; Khalansky AS; Gurina OI; Yusubalieva GM; Grinenko NP; Gubskiy IL; Melnikov PA; Kardashova KSh; Kabanov AV; Chekhonin VP
Drug Deliv; 2015 May; 22(3):276-85. PubMed ID: 24437962
[TBL] [Abstract][Full Text] [Related]
4. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43.
Chekhonin VP; Baklaushev VP; Yusubalieva GM; Belorusova AE; Gulyaev MV; Tsitrin EB; Grinenko NF; Gurina OI; Pirogov YA
Nanomedicine; 2012 Jan; 8(1):63-70. PubMed ID: 21703991
[TBL] [Abstract][Full Text] [Related]
6. Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy.
Sundarraj S; Thangam R; Sujitha MV; Vimala K; Kannan S
Toxicol Appl Pharmacol; 2014 Mar; 275(3):232-43. PubMed ID: 24467950
[TBL] [Abstract][Full Text] [Related]
7. Development of zwitterionic polymer-based doxorubicin conjugates: tuning the surface charge to prolong the circulation and reduce toxicity.
Wang Z; Ma G; Zhang J; Lin W; Ji F; Bernards MT; Chen S
Langmuir; 2014 Apr; 30(13):3764-74. PubMed ID: 24617705
[TBL] [Abstract][Full Text] [Related]
8. [Connexin 43 gene in the in vivo treatment of cerebral glioma in C6 rats].
Xia Z; Pu P; Huang Q; Zhang Y; Jiang Y; You Y
Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):212-4. PubMed ID: 12515608
[TBL] [Abstract][Full Text] [Related]
9. Polymeric nanoparticles with encapsulated superparamagnetic iron oxide and conjugated cisplatin for potential bladder cancer therapy.
Huang C; Neoh KG; Xu L; Kang ET; Chiong E
Biomacromolecules; 2012 Aug; 13(8):2513-20. PubMed ID: 22793172
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of cisplatin from pH-thermal dual responsive nanogels.
Peng J; Qi T; Liao J; Chu B; Yang Q; Li W; Qu Y; Luo F; Qian Z
Biomaterials; 2013 Nov; 34(34):8726-40. PubMed ID: 23948167
[TBL] [Abstract][Full Text] [Related]
11. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
Hu B; Du HJ; Yan GP; Zhuo RX; Wu Y; Fan CL
Drug Deliv; 2014 May; 21(3):204-12. PubMed ID: 24117028
[TBL] [Abstract][Full Text] [Related]
12. Methoxypoly(ethylene glycol)-block-poly(L-glutamic acid)-loaded cisplatin and a combination with iRGD for the treatment of non-small-cell lung cancers.
Song W; Li M; Tang Z; Li Q; Yang Y; Liu H; Duan T; Hong H; Chen X
Macromol Biosci; 2012 Nov; 12(11):1514-23. PubMed ID: 23070837
[TBL] [Abstract][Full Text] [Related]
13. Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in glioma.
Jang SJ; Kang JH; Kim KI; Lee TS; Lee YJ; Lee KC; Woo KS; Chung WS; Kwon HC; Ryu CJ; Choi TH; Choi CW; Lim SM; Cheon GJ
Cancer Lett; 2010 Nov; 297(1):84-90. PubMed ID: 20819721
[TBL] [Abstract][Full Text] [Related]
14. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
15. One-pot aqueous synthesis of sub-10 nm responsive nanogels.
Li L; Chang A; Hu Y; Zhang L; Wu W
Chem Commun (Camb); 2013 Jul; 49(58):6534-6. PubMed ID: 23756418
[TBL] [Abstract][Full Text] [Related]
16. Ras inhibition amplifies cisplatin sensitivity of human glioblastoma.
Messina S; Leonetti C; De Gregorio G; Affatigato V; Ragona G; Frati L; Zupi G; Santoni A; Porcellini A
Biochem Biophys Res Commun; 2004 Jul; 320(2):493-500. PubMed ID: 15219856
[TBL] [Abstract][Full Text] [Related]
17. Malignant Glioma Therapy by Vaccination with Irradiated C6 Cell-Derived Microvesicles Promotes an Antitumoral Immune Response.
Pineda B; Sánchez García FJ; Olascoaga NK; Pérez de la Cruz V; Salazar A; Moreno-Jiménez S; Hernández Pedro N; Márquez-Navarro A; Ortiz Plata A; Sotelo J
Mol Ther; 2019 Sep; 27(9):1612-1620. PubMed ID: 31204210
[TBL] [Abstract][Full Text] [Related]
18. Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery.
Lei Y; Wang J; Xie C; Wagner E; Lu W; Li Y; Wei X; Dong J; Liu M
J Gene Med; 2013; 15(8-9):291-305. PubMed ID: 24038955
[TBL] [Abstract][Full Text] [Related]
19. Experimental study on biodegradable polymer-paclitaxel conjugate micelles for chemotherapy of C6 glioma.
Wang Z; Hu X; Yue J; Jing X
J Control Release; 2011 Nov; 152 Suppl 1():e41-2. PubMed ID: 22195914
[No Abstract] [Full Text] [Related]
20. Cancer-stroma targeting therapy by cytotoxic immunoconjugate bound to the collagen 4 network in the tumor tissue.
Yasunaga M; Manabe S; Tarin D; Matsumura Y
Bioconjug Chem; 2011 Sep; 22(9):1776-83. PubMed ID: 21749132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
